Kovack Advisors’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
BTW
Kovack Advisors's ACLS Position: Q4 2024 in Review
Kovack Advisors sold out of Axcelis (ACLS) in Q4 2024, closing a stake of 3,280 shares — an estimated $344K sold.
Kovack Advisors first reported a position in ACLS in Q1 2023 and held it in 7 quarters. The position peaked at $417K in Q2 2024. 325 funds tracked by Wall St. Rank hold ACLS as of Q4 2024.
- Kovack Advisors reported no remaining Axcelis position as of Q4 2024 after selling out during the quarter.
- Kovack Advisors sold 3,280 Axcelis shares in Q4 2024, an estimated $344K.
- Kovack Advisors first reported a position in Axcelis in Q1 2023 and held it in 7 quarters.
- Kovack Advisors's Axcelis position peaked at $417K in Q2 2024.
- 325 funds tracked by Wall St. Rank held Axcelis as of Q4 2024.
Based on Kovack Advisors's 13F filing for Q4 2024, filed 5 Feb 2025.